ImportRefusal LogoImportRefusal

Jiangyin Tianjiang Pharmaceutical Co.Ltd

⚠️ Moderate Risk

FEI: 3004268522 • Jiangyin, Jiangsu • CHINA

FEI

FEI Number

3004268522

📍

Location

Jiangyin, Jiangsu

🇨🇳

Country

CHINA
🏢

Address

1 Xinsheng Road, Jiangyin Economic Zone, Jiangyin, Jiangsu, China

Moderate Risk

FDA Import Risk Assessment

42.6
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

14
Total Refusals
14
Unique Violations
7/19/2013
Latest Refusal
4/18/2003
Earliest Refusal

Score Breakdown

Violation Severity
70.4×40%
Refusal Volume
43.6×30%
Recency
0.0×20%
Frequency
13.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2385×

UNSAFE ADD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.

2514×

POISONOUS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a poisonous or deleterious substance which may render the article injurious to health. Contains:

37212×

PESTICIDE2

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be adulterated because it contains a pesticide chemical, which is in violation of section 402(a)(2)(B). Contains:

2182×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

3211×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

36811×

NCONTACTS

The product is a dietary supplement that is marketed in the United States and appears to not have a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

21201×

UNSFDIETSP

The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

31201×

EPHEDALK

The product is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a dietary supplement or a dietary ingredient that appears to contain ephedrine alkaloids, which presents an unreasonable risk of illness or injury under the conditions of use recommended or suggested in the labeling, or if no conditions of use are suggested in the labeling, under ordinary conditions of use.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
7/19/2013
54FBR20MINT (HERBAL & BOTANICALS, NOT TEAS - IF TEA FORM SEE 31P)
3721PESTICIDE2
Division of Northeast Imports (DNEI)
7/19/2013
54FCR25SCHIZANDRA (HERBAL & BOTANICALS, NOT TEAS)
3721PESTICIDE2
Division of Northeast Imports (DNEI)
5/21/2013
54F99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
218LIST INGRE
2300DIETARYLBL
3120EPHEDALK
320LACKS FIRM
321LACKS N/C
324NO ENGLISH
3681NCONTACTS
482NUTRIT LBL
Seattle District Office (SEA-DO)
1/4/2007
54ECR31ARISTOLOCHIA (FANGCHI), (HERBAL & BOTANICAL TEAS)
251POISONOUS
Florida District Office (FLA-DO)
1/4/2007
54ECR31ARISTOLOCHIA (FANGCHI), (HERBAL & BOTANICAL TEAS)
251POISONOUS
Florida District Office (FLA-DO)
1/4/2007
54ECR31ARISTOLOCHIA (FANGCHI), (HERBAL & BOTANICAL TEAS)
251POISONOUS
Florida District Office (FLA-DO)
3/3/2005
60CAR21EPHEDRINE (ADRENERGIC)
75UNAPPROVED
Seattle District Office (SEA-DO)
11/7/2003
54FBT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2120UNSFDIETSP
251POISONOUS
Los Angeles District Office (LOS-DO)
10/31/2003
46YG99FOOD ADDITIVES FOR HUMAN USE, N.E.C.
238UNSAFE ADD
New York District Office (NYK-DO)
10/31/2003
46YG99FOOD ADDITIVES FOR HUMAN USE, N.E.C.
238UNSAFE ADD
New York District Office (NYK-DO)
10/31/2003
46YG99FOOD ADDITIVES FOR HUMAN USE, N.E.C.
238UNSAFE ADD
New York District Office (NYK-DO)
10/31/2003
46YG99FOOD ADDITIVES FOR HUMAN USE, N.E.C.
238UNSAFE ADD
New York District Office (NYK-DO)
10/31/2003
46YG99FOOD ADDITIVES FOR HUMAN USE, N.E.C.
238UNSAFE ADD
New York District Office (NYK-DO)
4/18/2003
54EBT99HERBALS & BOTANICAL TEAS, N.E.C.
218LIST INGRE
473LABELING
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Jiangyin Tianjiang Pharmaceutical Co.Ltd's FDA import refusal history?

Jiangyin Tianjiang Pharmaceutical Co.Ltd (FEI: 3004268522) has 14 FDA import refusal record(s) in our database, spanning from 4/18/2003 to 7/19/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Jiangyin Tianjiang Pharmaceutical Co.Ltd's FEI number is 3004268522.

What types of violations has Jiangyin Tianjiang Pharmaceutical Co.Ltd received?

Jiangyin Tianjiang Pharmaceutical Co.Ltd has been cited for 14 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Jiangyin Tianjiang Pharmaceutical Co.Ltd come from?

All FDA import refusal data for Jiangyin Tianjiang Pharmaceutical Co.Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.